Arcutis to Present at Upcoming Investor Conference – Arcutis…
WESTLAKE VILLAGE, Calif., April 12, 2023 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. ARQTan early-stage commercial company focused on developing significant innovations in immunodermatology, today announced